Matthew B Yurgelun (Matthew Yurgelun)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 34

Top Topics

Metastatic Colorectal Cancer

Electronic Health Record

Neuroendocrine Tumors

Top Venues

Nature medicine

JCO precision oncology

Nature communications

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A Abrams, Jennifer A Chan, Eileen M Regan, Samuel J Klempner, Alison M Hannigan, Joshua Remland, Lauren K Brais, Elizabeth Andrews, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Lauren L Ritterhouse, Garrett Maron, Andrew J Aguirre, Jeffrey A Meyerhardt, Emma Gardecki, Jochen K Lennerz, Brian M Wolpin, Peter C Enzinger
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma. Nature communications 15 (1) (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor. Cancer immunology research (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor. Cancer immunology research (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor. Cancer immunology research 12 (9) (2024)
Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A Abrams, Jennifer A Chan, Eileen M Regan, Samuel J Klempner, Alison M Hannigan, Joshua Remland, Lauren K Brais, Elizabeth Andrews, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Lauren L Ritterhouse, Garrett Maron, Andrew J Aguirre, Jeffrey A Meyerhardt, Emma Gardecki, Jochen K Lennerz, Brian M Wolpin, Peter C Enzinger
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma. Nature communications 15 (1) (2024)
Asaf Maoz, Matthew B Yurgelun
Leveraging Electronic Health Record Data to Understand Gaps Underlying the Underdiagnosis of Lynch Syndrome. JCO clinical cancer informatics 8 (2024)
Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A Abrams, Jennifer A Chan, Eileen M Regan, Samuel J Klempner, Alison M Hannigan, Joshua Remland, Lauren K Brais, Elizabeth Andrews, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Lauren L Ritterhouse, Garrett Maron, Andrew J Aguirre, Jeffrey A Meyerhardt, Emma Gardecki, Jochen K Lennerz, Brian M Wolpin, Peter C Enzinger
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma. Nature communications 15 (1) (2024)
Pratyusha Bala, Jonathan P Rennhack, Daulet Aitymbayev, Clare Morris, Sydney M Moyer, Gina N Duronio, Paul Doan, Zhixin Li, Xiaoyan Liang, Jason L Hornick, Matthew B Yurgelun, William C Hahn, Nilay S Sethi
Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. Science advances 9 (13) (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine (2023)
Ana Babic, Michael H Rosenthal, Tilak K Sundaresan, Natalia Khalaf, Valerie Lee, Lauren K Brais, Maureen Loftus, Leah Caplan, Sarah Denning, Anamol Gurung, Joanna Harrod, Khoschy Schawkat, Chen Yuan, Qiao-Li Wang, Alice A Lee, Leah H Biller, Matthew B Yurgelun, Kimmie Ng, Jonathan A Nowak, Andrew J Aguirre, Sangeeta N Bhatia, Matthew G Vander Heiden, Stephen K Van den Eeden, Bette J Caan, Brian M Wolpin
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. Nature communications 14 (1) (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine (2023)
Rachel B Keller, Tali Mazor, Lynette M Sholl, Andrew J Aguirre, Harshabad Singh, Nilay S Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor J Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I Shapiro, Thomas A Abrams, Leah H Biller, Jennifer A Chan, James M Cleary, Steven M Corsello, Andrea C Enzinger, Peter C Enzinger, Robert J Mayer, Nadine Jackson McCleary, Jeffrey A Meyerhardt, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Osama E Rahma, Douglas A Rubinson, Jeffrey S Wisch, Matthew B Yurgelun, Michael J Hassett, Laura Macconaill, Deborah Schrag, Ethan Cerami, Brian M Wolpin, Jonathan Andrew Nowak, Marios Giannakis
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology 7 (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Rachel B Keller, Tali Mazor, Lynette M Sholl, Andrew J Aguirre, Harshabad Singh, Nilay S Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor J Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I Shapiro, Thomas A Abrams, Leah H Biller, Jennifer A Chan, James M Cleary, Steven M Corsello, Andrea C Enzinger, Peter C Enzinger, Robert J Mayer, Nadine Jackson McCleary, Jeffrey A Meyerhardt, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Osama E Rahma, Douglas A Rubinson, Jeffrey S Wisch, Matthew B Yurgelun, Michael J Hassett, Laura Macconaill, Deborah Schrag, Ethan Cerami, Brian M Wolpin, Jonathan Andrew Nowak, Marios Giannakis
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology 7 (2023)
Pratyusha Bala, Jonathan P Rennhack, Daulet Aitymbayev, Clare Morris, Sydney M Moyer, Gina N Duronio, Paul Doan, Zhixin Li, Xiaoyan Liang, Jason L Hornick, Matthew B Yurgelun, William C Hahn, Nilay S Sethi
Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. Science advances 9 (13) (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Pratyusha Bala, Jonathan P Rennhack, Daulet Aitymbayev, Clare Morris, Sydney M Moyer, Gina N Duronio, Paul Doan, Zhixin Li, Xiaoyan Liang, Jason L Hornick, Matthew B Yurgelun, William C Hahn, Nilay S Sethi
Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. Science advances 9 (13) (2023)
Rachel B Keller, Tali Mazor, Lynette M Sholl, Andrew J Aguirre, Harshabad Singh, Nilay S Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor J Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I Shapiro, Thomas A Abrams, Leah H Biller, Jennifer A Chan, James M Cleary, Steven M Corsello, Andrea C Enzinger, Peter C Enzinger, Robert J Mayer, Nadine Jackson McCleary, Jeffrey A Meyerhardt, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Osama E Rahma, Douglas A Rubinson, Jeffrey S Wisch, Matthew B Yurgelun, Michael J Hassett, Laura Macconaill, Deborah Schrag, Ethan Cerami, Brian M Wolpin, Jonathan Andrew Nowak, Marios Giannakis
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology 7 (2023)
Harshabad Singh, Rachel B Keller, Kevin S Kapner, Julien Dilly, Srivatsan Raghavan, Chen Yuan, Elizabeth F Cohen, Michael Yevgeniy Tolstorukov, Elizabeth Andrews, Lauren K Brais, Annacarolina F L Da Silva, Kimberley J Perez, Douglas A Rubinson, Rishi Surana, Marios Giannakis, Kimmie Ng, Thomas E Clancy, Matthew B Yurgelun, Benjamin L Schlechter, Jeffrey W Clark, Geoffrey I Shapiro, Michael H Rosenthal, Jason L Hornick, Valentina Nardi, Yvonne Y Li, Hersh V Gupta, Andrew D Cherniak, Matthew L Meyerson, James M Cleary, Jonathan Andrew Nowak, Brian M Wolpin, Andrew J Aguirre
Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kimberley J Perez, Matthew H Kulke, Anu Chittenden, Chinedu Ukaegbu, Kristina Astone, Holly Alexander, Lauren Brais, Jinming Zhang, John Garcia, Edward D Esplin, Shan Yang, Annacarolina Da Silva, Jonathan Andrew Nowak, Matthew B Yurgelun, Judy E Garber, Sapna Syngal, Jennifer Chan
Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs). JCO precision oncology 5 (2022)
Matthew B Yurgelun, Hajime Uno, C Sloane Furniss, Chinedu Ukaegbu, Miki Horiguchi, Amal Yussuf, Holly LaDuca, Anu Chittenden, Judy E Garber, Sapna Syngal
Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (35) (2022)
Brittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, Nabihah Tayob, Joanna Mercado, Israel Gomy, Anu Chittenden, Sarah Kane, Samantha Stokes, Melissa E Hughes, Ji Seok Kim, Renato Umeton, Mark M Awad, Panagiotis A Konstantinopoulos, Matthew B Yurgelun, Brian M Wolpin, Mary-Ellen Taplin, Randall E Newmark, Bruce E Johnson, Neal I Lindeman, Laura E MacConaill, Judy E Garber, Nancy U Lin
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Heather Hampel, Matthew B Yurgelun
Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for All GI Cancers? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (24) (2022)
Matthew B Yurgelun
Building on More Than 20 Years of Progress in Pancreatic Cancer Surveillance for High-Risk Individuals. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
David J Papke, Matthew B Yurgelun, Amy E Noffsinger, Kevin O Turner, Robert M Genta, Mark Redston
Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas. The New England journal of medicine 387 (18) (2022)
C Sloane Furniss, Matthew B Yurgelun, Chinedu Ukaegbu, Pamela E Constantinou, Catherine C Lafferty, Eliana R Talcove-Berko, Alison N Schwartz, Jill E Stopfer, Meghan Underhill-Blazey, Barbara Kenner, Scott H Nelson, Sydney Okumura, Sherman Law, Alicia Y Zhou, Tara B Coffin, Nicolette J Rodriguez, Hajime Uno, Allyson J Ocean, Florencia McAllister, Andrew M Lowy, Scott M Lippman, Alison P Klein, Lisa Madlensky, Gloria M Petersen, Judy E Garber, Michael G Goggins, Anirban Maitra, Sapna Syngal
Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer prevention research (Philadelphia, Pa.) 14 (11) (2021)
Suzanne P MacFarland, Jessica E Ebrahimzadeh, Kristin Zelley, Lubna Begum, Lee M Bass, Randall E Brand, Beth Dudley, Douglas S Fishman, Amanda Ganzak, Eve Karloski, Alicia J Latham, Xavier Llor, Sharon Plon, Mary K Riordan, Sarah R Scollon, Zsofia K Stadler, Sapna Syngal, Chinedu Ukaegbu, Jennifer M Weiss, Matthew B Yurgelun, Garrett M Brodeur, Petar Mamula, Bryson W Katona
Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing SMAD4/BMPR1A Variant. Cancer prevention research (Philadelphia, Pa.) 14 (2) (2020)
Chinedu Ukaegbu, Zohar Levi, Tara D Fehlmann, Hajime Uno, Anu Chittenden, Jennifer A Inra, Shilpa Grover, Fay Kastrinos, Sapna Syngal, Matthew B Yurgelun
Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals. Familial cancer 20 (2) (2020)
Leah H Biller, Chinedu Ukaegbu, Tara G Dhingra, Carol A Burke, Yana Chertock, Anuradha Chittenden, James M Church, Erika S Koeppe, Brandie H Leach, Elana Levinson, Ramona M Lim, Megan Lutz, Erin Salo-Mullen, Rania Sheikh, Gregory Idos, Fay Kastrinos, Elena Stoffel, Jennifer M Weiss, Michael J Hall, Matthew F Kalady, Zsofia K Stadler, Sapna Syngal, Matthew B Yurgelun
A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors. Cancer prevention research (Philadelphia, Pa.) 13 (3) (2020)